THALES: Ipsilateral Atherosclerotic Stenosis a Marker for Better 30-Day Ticagrelor Stroke Outcomes
A subgroup analysis of the THALES trial showed that ticagrelor added to aspirin reduced the 30-day risk of recurrent stroke by 27% in transient ischemic attack (TIA) and minor ischemic stroke patients with ipsilateral atherosclerotic stenosis of cervicocranial vasculature.